医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Taro to Announce Results for Year Ended March 31, 2015 on May 26, 2015

2015年05月20日 AM04:55
このエントリーをはてなブックマークに追加


 

HAWTHORNE, N.Y.

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today that it plans to release its financial results for the year ended March 31, 2015, on Tuesday, May 26, 2015.

The Company will conduct an earnings call at 8:00 am ET on Thursday, May 28, 2015, where senior management will discuss the Company’s performance and answer questions from participants.

The release will be accessible on Taro’s website at www.taro.com.

Earnings Call (8:00 am ET on Thursday, May 28, 2015)

To participate in this conference call, please dial the numbers provided below five to ten minutes ahead of the scheduled start time. The operator will provide instructions on asking questions before the call. You can also hear the call via an audio webcast, details of which will be announced later on the Company website, www.taro.com. A transcript of this earnings call will also be available on the website.

Summary of events

       
Event   Date and time   Telephone number/ website
Earnings release   May 26, 2015  

www.taro.com

Earnings conference call  

8:00 am ET

May 28, 2015

 

Participant Toll-Free Dial-In Number: +1 (844) 421-0601

Participant International Dial-In Number: +1 (716) 247-5800

ID: 49865423

 

Via audio webcast, details of which will be made available on www.taro.com

Replay of conference call   May 28, 2015 to

June 12, 2015

 

+ 1 (855) 859-2056 or +1 (404) 537-3406

ID: 49865423

 

Via audio webcast playback, details of which will be made available on www.taro.com

   

About Taro

Taro Pharmaceutical Industries Ltd. is a multinational, science-based pharmaceutical company, dedicated to meeting the needs of its customers through the discovery, development, manufacturing and marketing of the highest quality healthcare products. For further information on Taro Pharmaceutical Industries Ltd., please visit the Company’s website at www.taro.com.

View source version on businesswire.com: http://www.businesswire.com/news/home/20150519007083/en/

CONTACT

Taro Pharmaceutical Industries Ltd.
Michael Kalb, 914-345-9001
GVP,
CFO
Michael.Kalb@taro.com
or
William
J. Coote, 914-345-9001
William.Coote@taro.com

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • PotNetwork Holdings, Inc.第三季度业绩创纪录,营收超过610万美元
  • ポットネットワーク・ホールディングスが610万ドルを超える収益で過去最高の第3四半期を終える
  • ポットネットワーク・ホールディングスがSEC報告会社となるためにフォーム10を提出
  • Sinovac Granted Interim Injunctive Relief Regarding Filings Bearing a Falsified Company Seal and Forged Board Member Signatures
  • 2018年江戸川NICHE賞は幹細胞発見の功績によりジェームズ・ティル教授に授与へ